Skip to content

Study on Siddhathi ennai in Soothaga Vayu (Polycystic Ovarian Syndrome)

Clinical evaluation of Siddhathi ennai in the management of Soothaga Vayu (Polycystic Ovarian Syndrome) - A Pilot Study - NIL

Status
Active, not recruiting
Phases
Phase 2
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2024/03/064668
Enrollment
10
Registered
2024-03-22
Start date
Unknown
Completion date
Unknown
Last updated
2024-04-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: E282- Polycystic ovarian syndrome

Interventions

Intervention1: Siddhathi Ennai: 3 to 5 drops, Once a Day with Sombu Kudineer for 45 days Control Intervention1: Not applicable: Not applicable

Sponsors

Ayothidoss Pandithar Hospital, National Institute of Siddha
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Married / unmarried women aged between 18-40 years 2. Amenorrhoea (absence of menstruation more than 3 months) 3. Oligomenorrhoea (menstrual bleeding less than 2 days) 4. Irregular menstruation (8 cycles/year or more than 35 days between the cycles) 5. Polycystic ovary in recent ultrasound scan (Unilateral / Bilateral) (more than 12 antral follicles in one ovary and or ovarian volume more than 10cm3) 6. Hyperandrogenism 7. Hirsutism 8. Patients who are willing to co-operate for specific and routine blood investigations. 9. Patients who are willing to sign informed consent.

Exclusion criteria

Exclusion criteria: 1. K/C/O Hyperthyroidism / Hypothyroidism 2. K/C/O Diabetes mellitus / Hypertension 3. K/C/O Congenital uterine defects 4. K/C/O Pituitary /adrenal disorders 5. K/C/O Haemorrhagic / chocolate cyst 6. K/C/O Tuberculosis of ovary or uterus 7. Breast feeding mothers 8. Any other systemic illness

Design outcomes

Primary

MeasureTime frame
The expected outcome will be assessed through improvement in the clinical symptoms, the hormonal profile and ovarian volume/size of the patients. Timepoint: 45 days

Secondary

MeasureTime frame
Quality of life of the PCOS patients will be assessed using Polycystic Ovary Syndrome Questionnaire, Beck Depression Inventory and Scoff Questionnaire (for eating disorders).Timepoint: 45 days

Countries

India

Contacts

Public ContactDr A M Amala Hazel

National Institute of Siddha

dramalaaruldhas@gmail.com9486909809

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026